<DOC>
	<DOC>NCT01369719</DOC>
	<brief_summary>Thalassemic patients often suffer from iron overload due to frequent blood transfusion. Oral iron chelators reduce iron overload in transfusion dependent patients. The aim of this study is to compare the efficacy and safety of osveral and desferal in transfusional iron overload patients with Î²-Thalassemia and intermediate Thalassemia in Bandarabbas.</brief_summary>
	<brief_title>Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron Overload</brief_title>
	<detailed_description>This is a double blinded randomized controlled trial on Efficacy and safety of Osveral and Desferal in thalassemic patients.</detailed_description>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>Confirmed intermedia or major thalassemia More then 2 years old Serum Ferritin level &gt; 1000 Normal Creatinine and Complete Blood Count (CBC) HCV, HBV or HIV positive patients</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Iron overload</keyword>
	<keyword>transfusion</keyword>
	<keyword>osveral</keyword>
	<keyword>desferal</keyword>
</DOC>